Sign in

CIK 0000014272

  • Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
220790350
Phone
+1 609-252-4621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-04-25 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Purchase +4,250 $47.58 $202K 83,513.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Exercise or conversion +4,886 68,818.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other disposition −337 68,481.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −2,327 $63.11 $147K 66,154.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Exercise or conversion +4,765 70,919.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other disposition −831 70,088.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −2,013 $63.11 $127K 68,075.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Exercise or conversion +5,854 73,929.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other disposition −998 72,931.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −2,484 $63.11 $157K 70,447.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Exercise or conversion +28,593 99,040.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other disposition −10,545 88,495.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −9,232 $63.11 $583K 79,263.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Exercise or conversion · Market Share Units −4,886 0
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Exercise or conversion · Market Share Units −4,765 4,767
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Exercise or conversion · Market Share Units −5,854 11,711
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Grant or award · Market Share Units +35,146 35,146
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Exercise or conversion · Performance Shares −28,593 0
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Grant or award · Performance Shares +52,720 52,720
2025-02-14 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Purchase +1,823.49 $54.84 $100K 63,932.49

Page 1 of 5 · 83 trades